β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells
Background/Aims: β-catenin is an integral component of the canonical Wnt signaling pathway, and its mutations are an autosomal recessive cause of colorectal cancer (CRC), medulloblastoma (MDB), and ovarian cancer. Nevertheless, little is known about its function in lung cancers. Methods: We first kn...
Main Authors: | Wendan Yu, Liren Li, Fufu Zheng, Wenjing Yang, Shilei Zhao, Chunfang Tian, Wenwen Yin, Yiming Chen, Wei Guo, Lijuan Zou, Wuguo Deng |
---|---|
Format: | Article |
Language: | English |
Published: |
Cell Physiol Biochem Press GmbH & Co KG
2017-11-01
|
Series: | Cellular Physiology and Biochemistry |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/485013 |
Similar Items
-
Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells
by: Yuanyuan Tang, et al.
Published: (2018-03-01) -
Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
by: Vinay K. Kartha, et al.
Published: (2018-07-01) -
The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300
by: Agnes I. Lukaszewicz, et al.
Published: (2019-07-01) -
Molecular insights of a CBP/β-catenin-signaling inhibitor on nonalcoholic steatohepatitis-induced liver fibrosis and disorder
by: Kenzaburo Yamaji, et al.
Published: (2023-10-01) -
Multiple functions of CREB-binding protein during postembryonic development: identification of target genes
by: Amit Roy, et al.
Published: (2017-12-01)